EUS-guided Entero-biliary Anastomosis for Therapeutic Access in Benign Biliary Obstructions
Recruiting
Observational Study
Cholangiopancreatography, Endoscopic Retrograde
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 50 (estimated)
- Sponsor
- Hospital del Rio Hortega · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Background: Transpapillary EUS-BD (rendezvous/antegrade) is gaining acceptance in BBO. The potential of transmural EUS-BD (hepaticogastrostomy/choledochoduodenostomy) in complex BBO warrants study.
Aims: To assess feasibility and efficacy of TEA using transmural covered self-expandable metal-stents (cSEMS) to provide interval biliary drainage and create TAF for biliary endotherapy under cholangio…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* • Consecutive patients ≥ 18 years old.
* Benign biliary obstruction.
* ERCP failed or where ERCP could not be performed due to surgically-altered anatomy
Exclusion Criteria:
* • Refusal to sign the informed consent.
* Malignant biliary obstruction
* Coagulopathy (I…
Contacts